Mariella Filbin – Pediatric neuro-oncologist at Dana-Farber Cancer Institute and Boston Children’s Hospital, and Associate Professor at Harvard Medical School. Her research focuses on pediatric high-grade gliomas, using single-cell and molecular approaches to uncover therapeutic targets.
Antonio Chiocca – Chair of Neurosurgery at Brigham and Women's Hospital and Professor at Harvard Medical School. He is a leader in brain tumor research, focusing on glioblastoma and developing gene and immune-based therapies, including oncolytic viruses.
Maria G. Castro – Professor at the University of Michigan, Maria Castro researches glioblastoma and pediatric brain tumors. She focuses on the tumor microenvironment and develops immune and gene-based therapies, including for DIPG.
Peter Dirks – Based at the University of Toronto and The Hospital for Sick Children, Peter Dirks is a world-renowned pediatric neurosurgeon and cancer researcher. He is widely recognized for his discovery of brain tumor-initiating cells and his contributions to understanding the biology of glioblastoma and medulloblastoma.
Dinorah Friedmann-Morvinski – A leading researcher at Tel Aviv University, Israel, Dinorah Friedmann-Morvinski investigates the molecular mechanisms underlying glioblastoma initiation and progression. Her work focuses on gene therapy and reprogramming strategies to treat aggressive brain tumors.
Florent Ginhoux – Principal investigator at Institut Gustave Roussy, France, Florent Ginhoux is a prominent immunologist whose research centers on myeloid cells, especially microglia and their role in brain development and cancer. He has made key contributions to mapping the origins and functions of tissue-resident immune cells.
Dolores Hambardzumyan – Professor at the Icahn School of Medicine at Mount Sinai in the USA, Dolores Hambardzumyan explores the glioma microenvironment, particularly the roles of immune cells in tumor growth and therapy resistance. Her work aims to develop new immunotherapeutic strategies for brain tumors.
Christel Herold-Mende – A neurosurgeon and cancer researcher at University Hospital Heidelberg, Germany, Christel Herold-Mende focuses on glioblastoma biology, tumor heterogeneity, and patient-derived models. She aims to improve personalized treatment approaches through translational research.
Chris Jones – Based at the Institute of Cancer Research, UK, Chris Jones is a leader in the field of pediatric brain tumors. His research focuses on the molecular biology of high-grade gliomas in children and developing precision medicine approaches for these aggressive cancers.
Bozena Kaminska – A professor at the Nencki Institute of Experimental Biology in Poland, Bozena Kaminska studies molecular and immunological mechanisms of gliomas. She is particularly interested in how the tumor microenvironment and immune system interact during brain tumor progression.
Pedro Lowenstein – A professor at the University of Michigan, USA, Pedro Lowenstein is a pioneer in the development of gene therapies for brain cancer. His work combines virology, neurobiology, and immunology to devise novel treatments for glioblastoma.
Jacek Majewski – Geneticist and bioinformatics expert at McGill University, Canada, Jacek Majewski focuses on identifying genomic alterations in neurological disorders and brain cancers. His work leverages next-generation sequencing to understand disease mechanisms at the molecular level.
Duane Mitchell—Duane Mitchell is a neuro-oncology researcher at the University of Florida, USA, known for his groundbreaking work in cancer immunotherapy. He develops innovative vaccines and cellular therapies to treat malignant brain tumors.
Michael Platten – Chair of the Department of Neurology at the University of Heidelberg and a division head at the German Cancer Research Center (DKFZ), Michael Platten specializes in brain tumor immunotherapy. His research focuses on immunosuppressive mechanisms and therapeutic vaccines in glioma.
Steven Pollard – Professor at the University of Edinburgh, UK, Steven Pollard investigates the biology of glioblastoma stem cells and neural development. His work aims to uncover therapeutic vulnerabilities in brain tumors using stem cell and epigenetics-based approaches.
Radoslaw Rola – Neuroscientist at the Medical University of Lublin, Poland, Radoslaw Rola focuses on the effects of radiation on the brain and the biology of gliomas. He studies the neural stem cell niche and its role in tumor development.
Patrick Roth – A neuro-oncologist at the University of Zurich, Switzerland, Patrick Roth works on immunological aspects of gliomas. His research investigates how tumors evade immune detection and how immunotherapies can be optimized in brain cancer.
Felix Sahm – Neuropathologist at University Hospital Heidelberg and DKFZ, Germany, Felix Sahm explores diagnostic and molecular markers of brain tumors. His work supports the classification and targeted treatment of gliomas using integrated genomic approaches.
Ronit Satchi-Fainaro – Professor at Tel Aviv University, Israel, Ronit Satchi-Fainaro is a leader in cancer nanomedicine. She develops targeted drug delivery systems and 3D cancer models to study tumor vasculature and improve brain cancer therapies.
Lisa Sevenich – Based at the German Cancer Consortium (DKTK) and Frankfurt Cancer Institute, Lisa Sevenich studies the interaction between brain tumors and the immune system. Her research emphasizes tumor-associated macrophages and their role in glioma progression.
Mario Suvà – Physician-scientist affiliated with the Broad Institute, Massachusetts General Hospital, and Harvard Medical School, USA, Mario Suvà is a pioneer in single-cell transcriptomics. His work has illuminated the cellular diversity and plasticity of gliomas, with implications for personalized treatment.
Lene Uhrbom – Professor at Uppsala University, Sweden, Lene Uhrbom specializes in developing animal models of glioma to study tumor initiation and progression. Her research aims to identify novel therapeutic targets for malignant brain tumors.
Varun Venkataramani – Researcher at University Hospital Heidelberg, Germany, Varun Venkataramani studies the cellular networks formed by glioma cells. His research highlights how tumor cells communicate via tumor microtubes, contributing to therapy resistance.